all report title image

CHEMILUMINESCENCE IMAGING MARKET ANALYSIS

Chemiluminescence Imaging Market, by Application Type (Chemiluminescence Immunoassay, DNA Hybridization, Western Blotting, Southern Blotting, Hormones (Insulin, Thyroxin, Estradiol), Vitamin (Vit 12), Forensic Sciences, Southern Blotting ,Tumor Marker, and Others), by End User (Diagnostics Laboratory, Research and Academic Institutes, Forensic Laboratories, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI2497
  • Formats :
      Excel and PDF
  • Industry : Medical Imaging

Market News

Key Development

In August 2017, Azure Biosystems Inc., launched Sapphire Biomolecular Imager, a next generation laser scanner system that offers fluorescent imaging in the Near IR (NIR) and Visible Wavelengths (RGB), true chemiluminescent imaging.

In September 2017, DiaSorin S.p.A., acquired ELISA technology business from Siemens. The objective of acquisition was to convert the current client base that uses ELISA tests towards CLIA technology solutions.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.